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Abstract 
Background 
Numbers of children and young people with Life-Limiting Conditions (LLC) are rising and 
increasing lifespans require young adults with LLC to transition to appropriate adult services.  
Aim 
To describe the prevalence of LLC in children and young adults by age, sex, diagnostic group, 
ethnicity and deprivation.  
Design 
A secondary analysis of the English Hospital Episode Statistics dataset was undertaken to 
calculate prevalence per 10000 population.  
Setting/Participants 
Individuals (0-40 years) with LLCs were identified within an English Hospital Episode 
Statistics dataset by applying a customized coding framework of ICD-10 disease codes. 
Results 
There were 462,962 inpatient hospital admissions for 92,129 individual patients with a LLC.  
Prevalence by age group is U shaped with the highest overall prevalence in the under one 
year age group (127.3 per 10000), decreasing until age 21-25 years (21.1 per 10000) before 
rising steeply to reach 55.5 per 10000 in the 36-40 year age group. The distribution by 
diagnostic group varies by age: congenital anomalies are most prevalent in children until age 
16-20 years with oncology diagnoses then becoming the most prevalent.  
Conclusions 
Non-malignant diagnoses are common in children and young adults and services that have 
historically focussed on oncological care will need to widen their remit to serve this 
population of life-limited patients. The diagnosis determining a patient’s LLC will strongly 
influence their palliative care service needs. Therefore understanding the diagnostic and 
demographic breakdown of this population of teenagers and young adults is crucial for 
planning future service provision. 
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Key Statements 
What is already known about the topic 
The prevalence of children with Life-limiting conditions is increasing, especially in the 16-19 
year age group. 
What this paper adds 
Overall non-malignant diagnoses are more common than oncological ones in all age groups. 
Prevalence of LLC is highest in deprived areas throughout the age groups. 
There are higher prevalence of LLC in non-white children and young adults. 
Implications for practice, theory or policy 
Palliative Care services aimed at children and young adults need to take account of the 
diagnostic and demographic breakdown of this population in order to develop efficient and 
equitable services. 
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Background 
Recent work has shown that the numbers of children and young people with Life-Limiting 
Conditions (LLC) and complex chronic conditions are rising1, 2. Although the highest 
prevalence of LLC is in the under one age group, the largest increase over the last ten years 
is in the 16-19 year olds1, leading to a large number of young adults who have been cared 
for by paediatric palliative care services requiring transition to adult services 3. Historically, 
adult palliative care services have tended to care for people with cancer in the end of life 
phase4 whereas paediatric services have tended to care for children and families with non-
malignant diagnoses5, 6 over many years7, 8. Recent, figures from England have, however, 
shown that although 56% of adult patients receiving care from palliative services required 
care for fewer than 90 days, 45% of adult patients admitted to specialist palliative care 
inpatient services were discharged home. This has highlighted the non-end of life services 
that they provide in addition to end of life care9. Palliative care for adults, commonly limited 
by constraints of resources, is often still a service that is offered once any disease directed 
care has failed in contrast to the paediatric model of care proposed by the World Health 
Organisation which states that “It begins when illness is diagnosed, and continues regardless 
of whether or not a child receives treatment directed at the disease.”9 
A recent systematic review of transition in paediatric palliative care found that although 
some conditions had disease specific transition routes e.g. oncology and cystic fibrosis, 
many young adults expressed concern at the lack of availability of age appropriate services 
similar to the care they had received in the paediatric service 10. Young adult uptake of adult 
specialist palliative care services (SPC) is low with only just over 200 patients aged 16-24 
accessing adult community palliative care services in 2011-12, 90 inpatients, 45 day care and 
432 receiving hospital support9. In the US children and young adults accounted for less than 
1% of all admissions to hospices that cared for both children and adults11 mainly due to lack 
of capacity to care for these patients. It is known that adult SPC providers have concerns 
over caring for this new and unfamiliar population of young adults and training needs have 
been established12. 
Planning services for this population of children and young adults can only be undertaken 
effectively if the clinical and demographic distribution of these patients are known. This 
study therefore aimed to describe the patterns of diagnoses by age group in children and 
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young adults with Life-Limiting Conditions in England in order to inform effective and 
equitable service provision. 
Methods 
Participants 
All individuals aged 0-40 years with a LLC residing in England were identified in the inpatient 
Hospital Episode Statistics dataset in 2009/10. An ICD-10 coding framework developed for 
an earlier study was used to identify the patients 1. Patients who were non-resident in 
England or aged above 40 years at the start of a hospital episode were excluded from the 
analyses. 
Age 
The age at the start of the first inpatient hospital episode was used to assign the five year 
age category for each patient; those patients aged under one year of age were categorised 
separately as they are known to have the highest prevalence of LLC 1. 
Diagnoses 
The diagnoses were grouped by main ICD-10 chapter for analysis; oncology, haematology, 
neurology, metabolic, respiratory, circulatory, gastrointestinal, genitourinary, perinatal, 
congenital anomaly and other. No attempt was made to prioritise multiple diagnoses for 
individuals therefore individuals may have more than one life-limiting diagnosis. As 
oncology diagnoses become more common with increasing age in adults, the results are 
displayed for the whole population of LLCs and also excluding those patients with an 
oncology only diagnosis.  
Ethnicity 
The data for each hospital episode included a code for ethnicity. Individuals with more than 
one ethnicity were assigned the most commonly reported ethnicity unless the most 
common ethnicity was ‘not known’13. This ensured that the same code for an individual’s 
ethnicity was assigned to all episodes (i.e. if coded White in first hospital episode and the 
second hospital episode but not known in the third hospital episode, they would be counted 
as White). The 16 census ethnic groups 14 were merged into four super-groups to avoid very 
small numbers in some groups;  
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 White (White: British, White: Irish, White: Other White),  
 South Asian (Asian or Asian British: Indian, Asian or Asian British: Pakistani, Asian or 
Asian British: Bangladeshi, Asian or Asian British: Other Asian),  
 Black (Black or Black British: Black Caribbean, Black or Black British: Black African, 
Black or Black British: Other Black) ,  
 Chinese & Other ethnic groups (Mixed: White and Black Caribbean, Mixed: White 
and Black African, Mixed: White and Asian, Mixed: Other Mixed, Chinese and Other 
Ethnic Group).  
Deprivation 
An index of multiple deprivation (IMD2007)15 score was assigned to each individual based 
upon their Lower Super Output Area (LSOA) of residence. An LSOA is a census geographical 
area built up of output areas. There are 32,482 LSOAs (2001 Census) in England with a 
population of between 1000-3000 per LSOA 16. The IMD scores were split into five equal 
categories based on the scores for the whole of England (20% of the LSOAs in each category) 
with category 1 being the highest deprivation and category 5 the lowest. 
Population at risk data used to calculate prevalence were mid-year estimates by age, sex 
and ethnic group obtained from ethpop.org.uk. 
Analyses 
Prevalence and 95% conﬁdence intervals (CIs) per 10 000 population (aged 0-40 years) were 
calculated overall, by gender, for each age group, by major diagnostic group and for each 
ethnic group.  
Ethics approval was not required for this project as anonymised data was used. Permission from the 
NHS Information Centre advisory group was given in order to access this data. All data 
manipulation was undertaken in Microsoft SQL server 2008; statistical analyses were 
undertaken in Stata version 12 (Stata Corp, College Station,TX). 
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Results 
There were 462,962 inpatient hospital admissions for 92,129 individual patients with a LLC 
in 2009/10. 
Prevalence 
There is a U shaped prevalence with the highest overall prevalence of (127.3 per 10000) in 
the under one age group, decreasing until age 21-25 years before rising steeply to reach 
55.5 per 10000 in the 36-40 year age group (Table 1). Excluding patients whose only 
diagnosis was oncology showed a similar pattern of prevalence but with a less marked rise 
in the 36-40 year age group (Table 2). 
Overall prevalence in males and females are similar (Table 1) but when analysed by age 
group the prevalence is higher in males than females until the age 21-25 years where 
females predominate and the gap widens to 60.7 per 10000 female (95%CI 59.5,61.8) and 
50.1 per 10000 (95%CI 49.0,51.1) male by age 36-40 years. The gender differences are 
altered when the prevalence is assessed excluding those with an oncology only diagnosis 
(Table 2):overall in this group males have significantly higher prevalence compared to 
females. Again, males have a higher prevalence until age 21-25 years and then the 
prevalence is not significantly different. 
Major Diagnoses 
Overall, congenital anomalies have the highest prevalence in children until age 16-20 years 
when oncology diagnoses becomes the most prevalent, rising steeply in early adulthood to 
25.2 per 10000 by age 36-40 years. Neurology diagnoses have the second highest 
prevalence from age 1-5 years through to the 36-40 year age group when genitourinary 
diagnoses have a similar prevalence (Figure 1a). There are some differences by gender (data 
not shown); in males whereby oncology diagnoses do become the most prevalent diagnostic 
group (18.4 per 10000) in the age 16-20 age group but genitourinary (10.1 per 10000) and 
circulatory (8.5 per 10000) diagnoses are the second and third most prevalent diagnoses by 
age 36-40 years. In the female population the diagnostic pattern shows a more marked 
increase in oncology diagnoses after age 16-20 years with the highest prevalence of 31.6 per 
10000 in the oldest age group. Neurology diagnoses have the second highest prevalence in 
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the oldest age group in females (10.8 per 10000) with genitourinary third with 7.8 per 10000 
population. 
Ethnicity 
The number of patients in each ethnic group was: White 67,467, Black 3,822, South Asian 
8,350 and Chinese, Mixed and Other 4,066. Ethnic group was coded as not known for 9.1% 
of the patients. 
Higher prevalences in non-White ethnic groups were most noticeable in the two youngest 
age groups where prevalence is higher in Black and South Asian children. The differences 
were less marked in teenagers but a higher prevalence in the Black population was evident 
in the 30 plus age groups (Figure 2a). When the oncology only diagnoses patients are 
excluded, these patterns with ethnic groups persist (Figure 2b). 
Deprivation 
Figure 3a shows that throughout the age groups the prevalence is higher in the most 
deprived category and in the majority of the age groups a linear association is evident with 
the lowest prevalence in the least deprived category. The differences between prevalence 
for the deprivation categories are most evident in the under 5 and over 30 year age groups. 
When the oncology only diagnoses patients are excluded, these patterns with deprivation 
categories persist (Figure 3b). 
Discussion 
The U shaped prevalence pattern of Life-Limiting Conditions with age is informative when 
planning services as the age when transition would be occurring parallels the lowest 
prevalence. At this lowest point there are still more than 8000 patients living in England 
with a LLC who may require access to appropriate palliative care services, but then 
prevalence rises as age increases, raising the concern that these young people joining the 
population after the point of transition may find accessing services more difficult.  
The gender differences in overall prevalence of LLC in young adults are accounted for by the 
higher frequency of oncology diagnoses in the female population.  
The higher prevalence of some LLCs in ethnic minority groups has been reported previously 
although they have a lower incidence of most cancers compared to the White population, 
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they do have poorer survival for some cancers 9. Whilst it is encouraging that some 
paediatric services report growing numbers of patients from non-White ethnic groups 7, 17 a 
recent report focusing on end of life care in adults has shown that ethnic minority groups 
have lower access to and receipt of palliative and end of life services compared to White 
British people 18. This report has highlighted the need to involve ethnic minority groups in 
research and service planning for the future especially since non-White British populations 
are expected to grow in the next few decades19. Community engagement was important in 
the process of gaining understanding and acceptance of the concept of palliative care in the 
South Asian community in Yorkshire which has resulted in a marked increase in referrals to 
the local children’s hospice7. 
The linear association between prevalence of LLC and deprivation was expected and 
confirms previous work in this area1 although the differences between the deprivation 
categories are more noticeable in the young children and older adult age groups. The 
highest prevalence of LLC in the areas of highest deprivation may indicate higher incidence 
of LLC in areas of high deprivation or this may be the result of the financial burden of having 
a LLC resulting in families moving to areas of higher deprivation. Further research is required 
in this area. 
The numbers of 16 – 24 years olds accessing adult SPC services is a very small proportion20 
of the 15,000 adults of this age living with a LLC. This in part may be explained by the fact 
that paediatric SPC services often care for the young adult population3 (Children’s Hospices 
had 120 new referrals age 16+ in 2011/12 and 1780 patients in total aged 16+ being cared 
for) but further research is required to fully explain this discrepancy. This discrepancy is 
seen also in the US with less than 1% of admission to hospice organizations that care for 
children and adults were children and young adults11. 
Providing a service for patients with conditions which have very different disease 
trajectories can be challenging. Within the paediatric palliative care setting children with 
non-oncology diagnoses tend to be cared for by the services for longer periods of time than 
children with an oncology diagnosis 7 and this may have implications for young adults. Adult 
specialist palliative care services in England are caring for an increasing number of patients 
with non-oncology diagnoses, accounting for 11% of inpatients in 2011/12 compared to 3% 
in 1997/820 so developing these services for younger adults should be feasible. However, 
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adolescents and young adults with LLC do have some unique physical and psychosocial 
needs4, 6 in particular in relation to sexuality and reproduction but also due to reliance on 
parents and loss of peer interaction due to hospital stays etc. These needs need to be 
addressed by specialist palliative care services. Peer support is important for these patients 
21 which may be more difficult in the traditional adult palliative care services where the 
majority of patients are elderly. 
Another layer of complexity to consider when developing a palliative care service for young 
adults is the provision of  a service for patients who had a LLC diagnosed in childhood  who 
may have experienced paediatric palliative care services and also patients who have been 
diagnosed with a Life-Limiting or Life-Threatening Condition as a young adult. The life 
experience of these two groups are likely to be quite different, and the needs and 
expectations of these two groups of patients may differ considerably22. Currently transition 
planning is poor or absent in the majority of cases23, 24. For those transferring from 
paediatric services it is known that transition programmes are dependent on collaboration 
between children’s and adult services25, 26. Therefore paediatric palliative care services need 
to be involved in the development of palliative care services for young people with LLC and 
there is currently a call to start to plan transition with their patients from age 14 27.  
Limitations 
The prevalence estimates rely on correct identification of the individual’s diagnosis within 
the routine administrative dataset, a variable dependent on accurate diagnostic coding. 
There is no reason to believe that poor quality coding would be different by LLC and 
therefore would not substantially alter the prevalence estimates. Some patients with a LLC 
may not have had a hospital admission during this period and therefore our prevalence 
figures may represent a minimum. 
Ethnicity data was missing for 9.1% of the patients within this dataset so depending on 
whether the missing data was biased by ethnicity, the prevalence of LLC in some of the 
ethnic subgroups may be higher than estimated in these analyses. 
Survival rates for some cancers are now very high and although these patients are 
categorised as having a LLC only a small proportion will need to access palliative care 
services. Presenting the results from these analyses including and excluding these patients 
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allows transparency but importantly the ethnic and deprivation inequalities persist whether 
the analyses include the patients with only an oncology diagnosis or not. 
Conclusions 
The prevalence of Life-Limiting Conditions in children and young adults is U shaped with 
higher prevalence in the under one year and 36-40 year age groups with the lowest 
prevalence in the 20-25 year age group. In young adults the higher prevalence is accounted 
for by patients with an oncology diagnosis.  
When considering service provision, young adults with LLCs are a distinct population with 
different needs than children or older adults LLCs. Also patients with oncology diagnoses 
usually have different needs from a palliative care service than patients with slowly 
degenerative diseases. Adult SPC services are familiar with the clinical management of 
cancer generally but may need to look at the specific needs of other non-malignant groups 
in order to provide an appropriate service22. The higher prevalence in ethnic minority 
groups revealed in this study also needs addressing. Encouraging young adults in ethnic 
minority groups to engage with SPC may require a different approach from that applied to 
older adults. Accessing any healthcare can be more challenging in areas of high deprivation, 
but particularly so when considering the needs of this vulnerable population, is also 
important when planning future palliative care services for these populations. 
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Table 1 Prevalence of All Life-Limiting Conditions in England in 2009/10 (0-40 years) 
All LLC 
 Total Males Females 
Age 
Group 
Number 
of 
Patients 
Prevalence per 
10000 
population 
95% 
Confidence 
Intervals 
Number 
of 
Patients 
Prevalence per 
10000 
population 
95% 
Confidence 
Intervals 
Number 
of 
Patients 
Prevalence per 
10000 
population 
95% 
Confidence 
Intervals 
< 1 year 8508 127.3 124.6 130.0 4820 140.8 136.9 144.8 3673 112.6 109.0 116.2 
1-5 years 10943 33.4 32.8 34.1 6208 37.2 36.3 38.1 4734 29.5 28.7 30.4 
6-10 
years 
6973 24.5 24.0 25.1 3878 26.9 26.0 27.7 3094 22.2 21.4 22.9 
11-15 
years 
7199 24.0 23.4 24.5 3928 25.7 24.9 26.5 3270 22.2 21.4 22.9 
16-20 
years 
7521 23.1 22.5 23.6 3926 24.1 23.3 24.8 3595 22.1 21.3 22.8 
21-25 
years 
8090 21.1 20.7 21.6 3974 20.8 20.1 21.4 4115 21.5 20.8 22.2 
26-30 
years 
10300 28.7 28.2 29.3 4698 27.2 26.5 28.0 5602 30.1 29.3 30.9 
31-35 
years 
12690 40.8 40.1 41.5 5677 37.1 36.1 38.0 7013 44.5 43.4 45.5 
36-40 
years 
19905 55.5 54.7 56.2 8797 50.1 49.0 51.1 11103 60.7 59.5 61.8 
     
TOTAL 92129 33.9 33.7 34.1 45906 33.9 33.6 34.2 46199 33.9 33.6 34.2 
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Table 2 Prevalence of Life-Limiting Conditions Excluding Oncology Only Diagnoses in England in 2009/10 (0-40 years) 
Excluding Oncology Only Diagnoses 
 Total Males Females 
Age 
Group 
Number 
of 
Patients 
Prevalence per 
10000 
population 
95% 
Confidence 
Intervals 
Number 
of 
Patients 
Prevalence per 
10000 
population 
95% 
Confidence 
Intervals 
Number 
of 
Patients 
Prevalence per 
10000 
population 
95% 
Confidence 
Intervals 
< 1 year 8395 125.6 122.9 128.3 4764 139.2 135.3 143.1 3616 110.9 107.3 114.5 
1-5 years 10466 32.0 31.4 32.6 5944 35.6 34.7 36.5 4521 28.2 27.4 29.0 
6-10 
years 
6537 23.0 22.5 23.6 3647 25.3 24.4 26.1 2890 20.7 19.9 21.4 
11-15 
years 
6556 21.8 21.3 22.4 3587 23.5 22.7 24.2 2968 20.1 19.4 20.9 
16-20 
years 
6439 19.7 19.3 20.2 3355 20.6 19.9 21.3 3084 18.9 18.2 19.6 
21-25 
years 
6247 16.3 15.9 16.7 3075 16.1 15.5 16.6 3172 16.6 16.0 17.2 
26-30 
years 
7229 20.1 19.7 20.6 3397 19.7 19.0 20.4 3832 20.6 19.9 21.2 
31-35 
years 
8427 27.1 26.5 27.7 4021 26.3 25.4 27.1 4406 27.9 27.1 28.8 
36-40 
years 
12524 34.9 34.3 35.5 6204 35.3 34.4 36.2 6318 34.5 33.7 35.4 
     
TOTAL 72820 26.8 26.6 27.0 37994 28.1 27.8 28.3 34807 25.6 25.3 25.8 
 
 
15 
 
 
Figure 1 
 
 
 
  
16 
 
 
  
17 
 
 
